An investigation into the prevalence of combination syndrome.

J Dent

King's College London Faculty of Dentistry, Oral & Craniofacial Sciences, Floor 22, Guy's Hospital, London, SE1 9RT, United Kingdom. Electronic address:

Published: March 2019


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objectives: To investigate the prevalence of Combination Syndrome, and to investigate if provision of a mandibular removable partial denture has any influence on the prevalence of Combination Syndrome.

Method: Patients attending Kings College London Dental Institute, Guys Hospital who wore maxillary conventional complete dentures opposing mandibular anterior teeth only, with or without mandibular partial dentures were examined by one examiner. Oral health, residual alveolar ridge and denture quality were assessed. Features putatively associated with Combination Syndrome were recorded. Patient ratings of dentures were recorded.

Results: 99 patients were recruited who were wearing maxillary removable complete dentures opposing only mandibular anterior teeth. Of these, 64 patients wore mandibular removable partial dentures and 35 patients did not. Only 8 patients displayed two features of Combination Syndrome and 38 patients displayed one feature of Combination Syndrome, excessive resorption of the anterior maxillary sextant. These findings are not compatible with previous research which suggested that the five features of Combination Syndrome were prevalent in patients wearing maxillary complete dentures opposing mandibular anterior teeth.

Conclusions: Evidence supporting the existence of Combination Syndrome was not discovered in this research. Prevalence of Combination Syndrome appeared to be low or non-existent. Patient treatment modalities and teaching in relation to Combination Syndrome may need to be modified.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdent.2019.01.016DOI Listing

Publication Analysis

Top Keywords

combination syndrome
36
prevalence combination
16
complete dentures
12
dentures opposing
12
opposing mandibular
12
mandibular anterior
12
combination
10
syndrome
9
mandibular removable
8
removable partial
8

Similar Publications

Use of progestin-only drospirenone-based pills in hyperandrogenic women with polycystic ovary syndrome.

Arch Gynecol Obstet

September 2025

Department of Women's and Children's Health Sciences and Public Health, Fondazione Policlinico Universitario A. Gemelli, IRCCS, L.Go Agostino Gemelli, 8, 00168, Rome, Italy.

Purpose: Polycystic ovarian syndrome (PCOS) is a common endocrine-metabolic disorder affecting about 10% of reproductive-age women. Characterized by hyperandrogenism and ovulatory dysfunction, PCOS often involves metabolic features due to insulin resistance. Traditional treatment with combined oral contraceptive pills (COCP) effectively manages hyperandrogenism and menstrual irregularities.

View Article and Find Full Text PDF

Identification and prioritization of gene sets associated with schizophrenia risk by network analysis.

Psychopharmacology (Berl)

September 2025

Institute of Cardiovascular Research, Sleep Medical Center, Department of Psychiatry, Fundamental and Clinical Research on Mental Disorders Key Laboratory of Luzhou, Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan Province, 646000, China.

Rationale: Genome-wide association studies (GWASs) are used to identify genetic variants for association with schizophrenia (SCZ) risk; however, each GWAS can only reveal a small fraction of this association.

Objectives: This study systematically analyzed multiple GWAS data sets to identify gene subnetwork and pathways associated with SCZ.

Methods: We identified gene subnetwork using dmGWAS program by combining SCZ GWASs and a human interaction network, performed gene-set analysis to test the association of gene subnetwork with clinical symptom scores and disease state, meanwhile, conducted spatiotemporal and tissue-specific expression patterns and cell-type-specific analysis of genes in the subnetwork.

View Article and Find Full Text PDF

Aim        To compare the results of primary percutaneous coronary intervention (PCI) for non-ST-segment elevation acute coronary syndrome (NSTE-ACS) in patients who recently recovered from COVID-19 with those not previously infected with SARS-CoV-2; to establish prognostic criteria for PCI complications, including stent thrombosis and restenosis (ST and SR) and progression of ischemic heart disease, and to determine ways to prevent them.Material and methods         In 2021, middle-aged patients admitted to the Baku Central Clinical Hospital with a diagnosis of acute coronary syndrome who underwent urgent myocardial revascularization using percutaneous balloon angioplasty of the occluded coronary artery (CA) with implantation of a second-generation intracoronary drug-eluting stent were divided into two observation groups: the main group of 123 patients who had COVID-19 in the previous 6 months, and the control group of 112 patients who were not previously infected with SARS-CoV-2. The immediate results of PCI were assessed according to the TIMI scale; complications were assessed both clinically, by the incidence of severe complications (major adverse cardiovascular events, MACE), and angiographically, by the incidence of early and late ST and SR, and de novo stenosis that developed during the two-year observation period.

View Article and Find Full Text PDF

Aim     To determine the prevalence and predictors for the development of newly diagnosed chronic heart failure (CHF) in patients with shortness of breath in long-term post-COVID syndrome.Material and methods            This screening cross-sectional clinical study was performed from April 2020 through April 2024, in two stages in an outpatient setting. At the first stage, 878 patients with shortness of breath were screened three or more months after COVID-19, and the presence of at least three diagnostic criteria for CHF, that were not in their history, was verified.

View Article and Find Full Text PDF

Severe aplastic anemia (SAA) is a life-threatening bone marrow failure syndrome that is caused primarily by immune-mediated destruction of hematopoietic stem cells. Traditional treatment relies on immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine (CSA). However, the toxicity and limited availability of ATG have spurred interest in ATG-free regimens.

View Article and Find Full Text PDF